PCSK9 Gene

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) is a gene involved in LDL receptor regulation that has been studied in relation to immune function, metabolism, and chronic illness. Variants in PCSK9 may influence how the body responds to infection, inflammation, and long-term recovery.

This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.

What is the PCSK9 gene?

PCSK9 encodes proprotein convertase subtilisin/kexin type 9, a protein involved in LDL receptor regulation. It belongs to the Metabolism category and is part of the Mitochondrial & Metabolic biological cluster. PCSK9 promotes LDLR degradation in lysosomes, reducing hepatic LDL uptake and increasing plasma LDL levels. Gain-of-function variants cause familial hypercholesterolemia; loss-of-function dramatically lowers LDL and cardiovascular risk.

Biological role and pathway

PCSK9 is involved in the LDL receptor regulation pathway, which plays a central role in regulating physiological processes relevant to immune defence, cellular energy, and systemic homeostasis. Genes within the Mitochondrial & Metabolic cluster work together to maintain balanced function across interconnected biological systems.

Variants in genes within this pathway may influence an individual's predisposition to altered function in these systems — particularly under conditions of physiological stress such as viral infection or prolonged illness.

PCSK9 and Long COVID / ME-CFS research

PCSK9 inhibitors are used for cardiovascular risk reduction and are being investigated in COVID-19. PCSK9 gain-of-function variants elevate LDL and cardiovascular risk; these may be relevant to the accelerated cardiovascular disease risk in Long COVID patients.

This information is based on published research and does not constitute medical advice. See references below.

Known genetic variants

The following variants (SNPs) in the PCSK9 gene have been studied in relation to metabolism and chronic illness. Each variant represents a single nucleotide position where individuals may carry different alleles.

Conditions studied in relation to PCSK9

Research into PCSK9 variants has explored associations with the following conditions. These are areas of scientific investigation and do not imply that PCSK9 causes or treats any condition.

Long CovidCardiovascularLipid DysregulationStatin Therapy

Genetic insights from DNA data

Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may include PCSK9 and related genes in the mitochondrial & metabolic pathway.

The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. Results are presented in plain English with appropriate scientific context, no medical jargon, no scare tactics. All results should be discussed with a qualified healthcare provider.

Related genes in the Mitochondrial & Metabolic pathway

PCSK9 does not act in isolation. The following genes are functionally related and may be analysed together for a more complete picture of your genetic predispositions.

Frequently asked questions

What is the PCSK9 gene and what does it do?

PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) is involved in LDL receptor regulation. PCSK9 promotes LDLR degradation in lysosomes, reducing hepatic LDL uptake and increasing plasma LDL levels. Gain-of-function variants cause familial hypercholesterolemia; loss-of-function dramatically lowers LDL and cardiovascular risk.

How may PCSK9 gene variants relate to Long COVID or ME/CFS?

PCSK9 inhibitors are used for cardiovascular risk reduction and are being investigated in COVID-19. PCSK9 gain-of-function variants elevate LDL and cardiovascular risk; these may be relevant to the accelerated cardiovascular disease risk in Long COVID patients.

Can a DNA test reveal information about my PCSK9 gene?

Consumer DNA data from 23andMe, AncestryDNA, and MyHeritage includes SNP variants for many genes. ChronicDNA analyses your raw DNA file and reports on variants that have been studied in relation to chronic illness, immune function, and metabolism. This is not a diagnostic service — results are informational and educational only.

Explore your PCSK9 genetic insights

Upload your DNA data from 23andMe, AncestryDNA, or MyHeritage and receive a personalised report covering >80 genes relevant to Long COVID and ME/CFS.

Get Your Personalised DNA Report

Informational and educational only · Not a diagnostic tool · GDPR compliant

References

The following publications were used in compiling the research context for PCSK9. This is not an exhaustive literature review.

  • [1]PMID: 26041305
  • [2]New England Journal of Medicine
  • [3]Nature